Home > Healthcare > Biotechnology > Biopharma > Bioink Market

Bioink Market Size

Report ID: GMI9118
Published Date: Oct 2024
Report Format: PDF

Download Free Sample

Bioink Market Size

The global bioink market was valued at USD 70.4 Million in 2023 growing at a CAGR of 12.5% from 2024 to 2032. The global market is experiencing dynamic growth, driven by factors such as the increasing application of bioink in biomedical research and therapy, and the rising incidence of chronic diseases and organ failure.

bioink market

To get key market trends

Download Free Sample

This heightened demand for innovative medical solutions, including bio-printed tissues and organs, is fueling the growth of the bioink market. Additionally, advancements in 3D bioprinting technology, supported by growing collaborations and partnerships between pharmaceutical companies and research institutes, are expected to further boost market growth. For instance, in July 2023, CD Bioparticles, a leading manufacturer and supplier of drug delivery products and services, announced the launch of a new line of bioinks for 3D bioprinting. These bioinks are designed to be biocompatible and versatile, making them ideal for applications such as 3D biological model construction, tissue engineering, and drug delivery.

Bioink Market Report Attributes
Report Attribute	Details
Base Year:	2023
Bioink Market Size in 2023:	USD 70.4 Million
Forecast Period:	2024 – 2032
Forecast Period 2024 – 2032 CAGR:	12.5%
2024 – 2032 Value Projection:	USD 202.1 Million
Historical Data for:	2021-2023
No. of Pages:	130
Tables, Charts & Figures:	183
Segments covered:	Type, Material, Application, Printing Modality, End Use, and Region
Growth Drivers:	Rising application in regenerative medicine Increase in demand for 3D printed tissue and organs Rise in prevalence of chronic disease and organ failure Advancement in bioprinting technologies
Pitfalls & Challenges:	Stringent approval filing process High manufacturing cost

Learn more about the key segments shaping this market

Download Free Sample

Bioink refers to any natural or synthetic polymer selected for its biocompatibility and favorable rheological properties. It typically supports living cells and aids in cell adhesion, proliferation, and differentiation during maturation. Bioink is used to produce engineered (artificial) live tissue using 3D printing technology. While it can be composed solely of cells, most bioinks include an additional carrier material that envelops the cells. This carrier material, usually a biopolymer film or gel, acts as a 3D molecular scaffold, allowing cells to attach, spread, grow, and proliferate.

Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

The bioink industry was valued at USD 70.4 million in 2023 and is estimated to grow at a 12.5% CAGR from 2024 to 2032, driven by increasing applications in biomedical research and therapy, and a rising incidence of chronic diseases and organ failures.

The natural bioinks segment recorded USD 60.7 million in 2023 and is expected to dominate the market due to their biocompatibility, non-toxicity, and sustainability.

The North America bioink market recorded a substantial share of 43.6% in 2023 and is expected to maintain its dominance throughout the forecast period. This growth is attributed to the availability of technologically advanced bioink products, such as improved printing resolution, multi-material printing capabilities, and integrated bioprinting systems.

Key players in the bioink industry include Allevi, Inc. (3D Systems), Axolotl Biosciences, BIO INX, CELLLINK (BICO), CollPlant Biotechnologies Ltd, Foldink, Gelomics, INNOREGEN, Inc., and Merck KGaA.